June 9, 2020 Price forecast | 2 weeks: 7.10% | 1 month: 7.40% | 3 months: 17.14% | Premium Forecast


TXMD stock forecast

Our latest prediction for TherapeuticsMD, Inc.'s stock price was made on the June 9, 2020 when the stock price was at 1.41$.

In the short term (2weeks), TXMD's stock price should outperform the market by 7.10%. During that period the price should oscillate between -10.71% and +21.80%.

In the medium term (3months), TXMD's stock price should outperform the market by 17.14%. During that period the price should oscillate between -43.69% and +55.94%.

Create a solid portfolio with TXMD

Add TXMD to your portfolio and optimize it!


About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. is a pharmaceutical company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The firm also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.

At the moment the company generates 58M USD in revenues.

On its last earning announcement, the company reported a loss of -0.77$ per share.

The book value per share is 0.03$

TherapeuticsMD, Inc. website


Three months stock forecastJune 9, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
58M 85.70% -164M -283.00% -193M -0.77 - - 254M 0.03 -167M -24M -190M